Put Options

3 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2018

May 15, 2018

SELL
$44.08 - $55.05 $299,744 - $374,340
-6,800 Closed
0 $0
Q4 2017

Feb 14, 2018

SELL
$50.3 - $64.39 $261,559 - $334,828
-5,200 Reduced 43.33%
6,800 $340,000
Q3 2017

Nov 14, 2017

BUY
$45.56 - $59.57 $546,720 - $714,840
12,000
12,000 $603,000

Others Institutions Holding IONS

About IONIS PHARMACEUTICALS INC


  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $5.35B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Highbridge Capital Management LLC Portfolio

Follow Highbridge Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Highbridge Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Highbridge Capital Management LLC with notifications on news.